Panasonic Corporation is taking part in the 41st Home Care and Rehabilitation Exhibition, H.C.R. 2014, which is being held at the Tokyo Big Sight from October 1 to 3, 2014.
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, announced today that it was selected by Boston Dynamics, now part of Google, to continue developing technologies for Defense Advanced Research Projects Agency's (DARPA's) Warrior Web Task A project. Ekso received a subcontract from Google for the project, in which Ekso Bionics will retain rights to its proprietary intellectual property.
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, announced today that it has signed a Memorandum of Understanding with SoldierSocks, a 501(c)(3) dedicated to working with veterans and veteran organizations. Over the next three years, SoldierSocks has established a goal of purchasing 80 Ekso GT™ robotic exoskeleton suits for VA Hospitals, organizations serving veterans, and eventually direct to veterans.
Intuitive Surgical, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the Single-Site Wristed Needle Driver for use in single-incision surgery. This latest addition to the Single-Site suite of instruments has been cleared for use with the da Vinci Si Surgical System for minimally invasive removal of the uterus (hysterectomy), the ovaries and fallopian tubes for benign conditions, as well as removal of the gallbladder.
Grégoire Courtine, who holds the International Paraplegic Foundation Chair in Spinal Cord Repair, has been awarded a PROOF OF CONCEPT GRANT from the European Research Council (ERC). Once again, the excellence of the research performed at EPFL has been recognised at an international level.
A new standardized assessment provides a useful tool for tracking surgeons' progress as they develop the skills needed to perform robot-assisted microsurgery, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
ReWalk Robotics Ltd. (d.b.a. Argo Medical Technologies in Germany) announced today that a major German insurance company is the first to reimburse a ReWalk system for Personal use. ReWalk Robotics has been working with insurers across the globe on reimbursement policies for its exoskeleton technology.
Pietro Valdastri, assistant professor of mechanical engineering at Vanderbilt University, and colleagues will continue to develop a unique endoscope for colonoscopy in patients with inflammatory bowel disease with the support of a 4-year, $1.5 million grant – “A magnetic capsule endoscope for colonoscopy in patients with IBD” – from the National Institute of Biomedical Imaging and Bioengineering, one of the 26 National Institutes of Health.
A new resource unveiled today by researchers from several Harvard University labs in collaboration with Trinity College Dublin provides both experienced and aspiring researchers with the intellectual raw materials needed to design, build, and operate robots made from soft, flexible materials.
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced new findings from a feasibility study conducted by Kessler Foundation, which reported that eight stroke patients who were prescribed gait training during inpatient rehabilitation training, safely increased their cadence (steps per minute) after six weeks of rehabilitation with the assistance of the Ekso™ GT robotic exoskeleton.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.